Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications.
Aaron S KesselheimMacarius DonneyongGerald J Dal PanEsther H ZhouJerry AvornSebastian SchneeweissJohn D SeegerPublished in: Pharmacoepidemiology and drug safety (2017)
The DSCs related to zolpidem-containing products shifted prescribing toward the lower-dose formulations, consistent with the recommendations in the DSCs. Copyright © 2017 John Wiley & Sons, Ltd.